Underdosing of other fibrinolysis-affecting drugs, sequela

This code indicates a patient is experiencing a long-term consequence or complication resulting from insufficient administration of a fibrinolysis-affecting drug. These medications are used to break down blood clots, and underdosing can lead to persistent or new thrombotic events or related issues. The sequela could manifest months or even years after the initial underdosing incident.

Apply this code when documentation clearly links a current medical condition or symptom to a past event of inadequate dosing of a fibrinolytic agent. This is appropriate for conditions like recurrent deep vein thrombosis, pulmonary embolism, or other thrombotic disorders that are a direct result of the previous underdosing. It signifies that the underdosing event is no longer active but has left a lasting impact.

• Always assign this code as a secondary diagnosis, following the code for the specific sequela being treated.
• Ensure the medical record explicitly states a causal link between the underdosing and the current condition, and that the underdosing event itself is no longer ongoing.
• Distinguish from acute underdosing (initial encounter) or subsequent care for an active underdosing event, which would use different seventh characters.